18F-FDG PET in the Management of Differentiated Thyroid Cancer in Patients with High Serum Thyroglobulin and Negative I-131 Whole Body Scan.

被引：0
|
作者：
Martins, R. G. [1 ]
Santos, A. P. [1 ]
Couto, J. [1 ]
Barbosa, A. P. [1 ]
Teixeira, J. [1 ]
Lucena, I. [1 ]
Bastos, L. [1 ]
Torres, I. [1 ]
机构：
[1] Portuguese Inst Oncol, Oporto, Portugal
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT
    Okuyucu, Kursat
    Ince, Semra
    Alagoz, Engin
    Emer, Ozdes
    San, Huseyin
    Balkan, Elif
    Ayan, Asli
    Meric, Coskun
    Haymana, Cem
    Acikel, Cengizhan
    Gunalp, Bengul
    Karacalioglu, Alper Ozgur
    Arslan, Nuri
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (03): : 208 - 217
  • [2] Stratification of recurrent differentiated thyroid cancer with elevated thyroglobulin and negative I-131 whole body scan by restaging 18F FDG PET/CT
    Okuyucu, K.
    Ince, S.
    Alagoz, E.
    Emer, O.
    San, H.
    Balkan, E.
    Ayan, A.
    Gunalp, B.
    Karacalioglu, A. O.
    Arslan, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S649 - S650
  • [3] Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in well-differentiated thyroid carcinoma patients with high serum thyroglobulin but negative I-131 whole body scan
    Kunawudhi, Anehisa
    Pak-Art, Rattaplee
    Keelawat, Somboon
    Tepmongkol, Supatporn
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] F-18 FDG-PET/CT Evaluation of Patients With Differentiated Thyroid Cancer With Negative I-131 Total Body Scan and High Thyroglobulin Level
    Bertagna, Francesco
    Bosio, Giovanni
    Biasiotto, Giorgio
    Rodella, Carlo
    Puta, Erinda
    Gabanelli, Sara
    Lucchini, Silvia
    Merli, Giuseppe
    Savelli, Giordano
    Giubbini, Raffaele
    Rosenbaum, Joshua
    Alavi, Abass
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (11) : 756 - 761
  • [5] Management impact of FDG PET/CT in patients with differentiated thyroid carcinoma: A comparative study with I-131 whole body scan and serum thyroglobulin
    Boktor, Raef
    Lee, Sze Ting
    Beriangieri, Saivatore
    Scott, Andrew
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] MANAGEMENT IMPACT OF FDG PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA: A COMPARATIVE STUDY WITH I-131 WHOLE BODY SCAN AND SERUM THYROGLOBULIN
    Boktor, R.
    Lee, S. T.
    Berlangieri, S. U.
    Scott, A. M.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 23 - 23
  • [7] Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Li, Hongyan
    Chen, Xiaomin
    Zhang, Yajing
    Wang, Kun
    Gao, Zairong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2869 - 2876
  • [8] Role of 18F-FDG PET in stage IV thyroid cancer with positive 131I whole body scan.
    Piccardo, A.
    Morbelli, S.
    Bianchi, P.
    Barbera, F.
    Villavecchia, G.
    Cabria, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S198 - S198
  • [9] 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative I-131 Whole Body Scan. It's Value Confirmed by a Bicentric Experience
    Bertagna, Francesco
    Albano, Domenico
    Bosio, Giovanni
    Piccardo, Arnoldo
    Dib, Bassam
    Giubbini, Raffaele
    CURRENT RADIOPHARMACEUTICALS, 2016, 9 (03) : 228 - 234
  • [10] Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan
    Martin, M. N. Cabrera
    Pingarron, J. A. Pasamontes
    Delgado, J. L. Carreras
    Gutierrez, Lapena
    Bolton, R. C. Delgado
    Copano, A. Bimni
    Castejon, M. J. Perez
    Perez, C. Fernandez
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2007, 26 (05): : 263 - 269
12345